Dirk is an MD, PhD with extensive experience in global drug development of anti-cancer drugs.
He did oncology research at Georgetown University, US, at the Institute of General Pathology at University of Kiel and at the Ivonex GmbH in Kiel, Germany.
After that he hold senior clinical development positions at Merck Serono, Novartis Pharma and Takeda Pharmaceuticals. He has worked in early- and late-stage clinical development programs which included interactions with all major regulatory authorities, dossier filing and lead of submission teams.
He also gained extensive experience in the planning and preparations required for several commercial product launches globally.